Patents by Inventor Andrew Edmund Taggi

Andrew Edmund Taggi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120149573
    Abstract: Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof, X is CH or N; Y is C(O) or S(O)2; provided that when Y is S(O)2, then X is CH; A is a radical selected from the group consisting of and B1, B2, B3, T, R1, R2 R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling undesired vegetation comprising contacting the undesired vegetation or its environment with an effective amount of a compound or a composition of the invention.
    Type: Application
    Filed: September 7, 2010
    Publication date: June 14, 2012
    Inventors: Kanu Maganbhai Patel, Thomas Paul Selby, Brenton Todd Smith, Andrew Edmund Taggi, Patrick Ryan Kovacs
  • Patent number: 8173797
    Abstract: The present invention is directed to new therapeutic compounds isolated from spider venom and methods of using these new compounds. The compounds are sulfated nucleoside derivatives including ribonucleoside mono- and disulfates derived from guanine, adenosine, and cytidine. Some of these compounds are glycosylated or fucosylated bearing one or more sugar residues.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: May 8, 2012
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Jerrold Meinwald, Andrew Edmund Taggi, Frank Clemens Schroeder
  • Publication number: 20110319430
    Abstract: Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein Q1 is a phenyl ring, naphthalenyl ring system, a 5- to 6-membered fully unsaturated heterocyclic ring or an 8- to 10-membered heteroaromatic bicyclic ring system, each as described with optional substituents as defined in the disclosure; Q2 is a phenyl ring, a naphthalenyl ring system, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated heterocyclic ring, or an 8- to 10-membered heteroaromatic bicyclic ring system, each as described with optional substituents as defined in the disclosure; X is O, S(O)m, NR4, CR15R16, C(?O) or C(?S); and R1, R1a, R2, R4, R15, R16 and m are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.
    Type: Application
    Filed: March 3, 2010
    Publication date: December 29, 2011
    Applicant: E.I. Du pont Nemours and Company
    Inventors: Jeffrey Keith Long, Wonpyo Hong, Andrew Edmund Taggi
  • Publication number: 20110045101
    Abstract: Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein J is Q2 or R1; X is N, CR2 or CQ3; Y is N or CR3; Z is N or CR4; and Q1, Q2, Q3, R1 R2 and R3 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.
    Type: Application
    Filed: May 7, 2009
    Publication date: February 24, 2011
    Applicant: E.I. Du Pont De Nemours and Company
    Inventors: Thomas Paul Selby, James Francis Bereznak, John Joseph Bisaha, Amy X. Ding, Mary Ann Hanagan, Jeffrey Keith Long, Andrew Edmund Taggi, Vijayagopal Gopalsamuthiram
  • Publication number: 20100273775
    Abstract: Disclosed are compounds of Formulae 1 and 1a, N-oxides, and salts thereof, wherein R1, R1a, Y, and J are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention. Further disclosed is a method for preparing compounds of Formula 1 from compounds of Formula 1a.
    Type: Application
    Filed: December 10, 2008
    Publication date: October 28, 2010
    Applicant: E.I. Du pont de Nemours and Company
    Inventors: John Joseph Bisaha, Alvin Donald Crews, JR., Michael Henry Howard, JR., Paula Louise Sharpe, Thomas Martin Stevenson, Andrew Edmund Taggi
  • Publication number: 20100267561
    Abstract: Disclosed are compounds of Formula 1, N-oxides, and salts thereof, wherein W1 is O or S, and R1, R2, R3, G and J are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling undesired vegetation comprising contacting the undesired vegetation or its environment with an effective amount of a compound or a composition of the invention.
    Type: Application
    Filed: December 19, 2008
    Publication date: October 21, 2010
    Inventors: Thomas Martin Stevenson, Eric Allen Marshall, Andrew Edmund Taggi
  • Publication number: 20100120714
    Abstract: Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein W is O or S; V is a direct bond or NR3; Q is or CR6aR6b, O, NR7, C?N—O—R7 or C(?O); Y is —C(R5)?N—O—(CR8aR8b)p—X—(CR9aR9b)q—SiR10aR10bR10c; or a phenyl ring substituted as defined in the disclosure; or Z; and R1, R2, R3, R4, R5, R6a, R7, R8a, R8b, R9b, R10a, R10b, R10c, Z, p and q are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.
    Type: Application
    Filed: April 4, 2008
    Publication date: May 13, 2010
    Applicant: E.I. DU PONT DE NEMOURS AND COMPANY
    Inventors: Bruce Lawrence Finkelstein, Andrew Edmund Taggi, Jefrey Keith Long, Paula Louise Sharpe, Chi-ping Tseng, Stephen Frederick Mccann, Amy X. Ding, Steven Lewis Swann, JR.
  • Publication number: 20090186907
    Abstract: This invention pertains to a method of inhibiting undesired animal cellular proliferation said method comprising contacting an animal cell with a compound of Formula 1 and all pharmaceutically acceptable, salts, N-oxides, hydrates, solvates, or geometric and stereoisomers thereof: wherein R1 is NR4R5, N?CR19R21, OR6, G1 or G2; or C1-C8 alkyl, C2-C8 alkenyl, each optionally substituted; A is O, S or NR7; R2 is cyano, NR8—N?CR9R10 or NC(?O)R30; or a 5- or 6-membered heteroaromatic ring, each ring or ring system optionally substituted; R3 is H, halogen, cyano, C1-C6 alkyl; J is C1-C8 alkyl or phenyl, optionally substituted; and R4, R5, R6, R7, R8, R9, R10, R19, R21, R30, G1 and G2 are as defined in the disclosure.
    Type: Application
    Filed: June 19, 2007
    Publication date: July 23, 2009
    Applicant: E.I. DuPont De Nemours and Company
    Inventors: James Francis Bereznak, Thomas Martin Stevenson, Andrew Edmund Taggi, Paula Louise Sharpe
  • Publication number: 20080194585
    Abstract: Compounds of Formula 1, and their N-oxides and agriculturally suitable salts, are disclosed as useful as fungicides (INSERT FORMULA I HERE) wherein R1 is NR4R5, N?CR19R21, OR6, G1 or G2; or C1-C8 alkyl, C2-C8 alkenyl, each optionally substituted; A is O, S or NR7; R2 is cyano, NR8 N?CR9R10, NC(?O)R30; or a 5- or 6-membered heteroaromatic ring, each ring or ring system optionally substituted; R?3? is H, halogen, cyano, C1-C6 alkyl; J is C1-C8 alkyl or phenyl, optionally substituted; and R4, R5, R6, R7, R8, R9, R10, R19, R21, R30, G and G2 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and a method for controlling plant diseases caused by fungal plant pathogens which involves applying an effective amount of a compound of Formula 1.
    Type: Application
    Filed: February 14, 2006
    Publication date: August 14, 2008
    Inventors: Paula Louise Sharpe, Thomas Martin Stevenson, James Francis Bereznak, Ritesh Sheth, Andrew Edmund Taggi, Chip-Ping Tseng, Wenming Zhang
  • Publication number: 20080193452
    Abstract: The present invention is directed to new therapeutic compounds isolated from spider venom and methods of using these new compounds. The compounds are sulfated nucleoside derivatives including ribonucleoside mono- and disulfates derived from guanine, adenosine, and cytidine. Some of these compounds are glycosylated or fucosylated bearing one or more sugar residues.
    Type: Application
    Filed: July 21, 2005
    Publication date: August 14, 2008
    Applicant: Cornell Research Foundation, Inc.
    Inventors: Jerrold Meinwald, Andrew Edmund Taggi, Frank Clemens Schroeder